Abo Bibliothek: Guest
Critical Reviews™ in Oncogenesis

Erscheint 4 Ausgaben pro Jahr

ISSN Druckformat: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Profiles of Radioresistance Mechanisms in Prostate Cancer

Volumen 23, Ausgabe 1-2, 2018, pp. 39-67
DOI: 10.1615/CritRevOncog.2018025946
Get accessGet access

ABSTRAKT

Radiation therapy (RT) is commonly used for the treatment of localized prostate cancer (PCa). However, cancer cells often develop resistance to radiation through unknown mechanisms and pose an intractable challenge. Radiation resistance is highly unpredictable, rendering the treatment less effective in many patients and frequently causing metastasis and cancer recurrence. Understanding the molecular events that cause radioresistance in PCa will enable us to develop adjuvant treatments for enhancing the efficacy of RT. Radioresistant PCa depends on the elevated DNA repair system and the intracellular levels of reactive oxygen species (ROS) to proliferate, self-renew, and scavenge anti-cancer regimens, whereas the elevated heat shock protein 90 (HSP90) and the epithelial–mesenchymal transition (EMT) enable radioresistant PCa cells to metastasize after exposure to radiation. The up-regulation of the DNA repairing system, ROS, HSP90, and EMT effectors has been studied extensively, but not targeted by adjuvant therapy of radioresistant PCa. Here, we emphasize the effects of ionizing radiation and the mechanisms driving the emergence of radioresistant PCa. We also address the markers of radioresistance, the gene signatures for the predictive response to radiotherapy, and novel therapeutic platforms for targeting radioresistant PCa. This review provides significant insights into enhancing the current knowledge and the understanding toward optimization of these markers for the treatment of radioresistant PCa.

REFERENZIERT VON
  1. Schlegel Jeanne, Chahwan Charles, Ait Said Khelifa, Vaudreuil Lionel, Seddik Sofiane, Tillou Xavier, Evaluation of the residual prostate cancer rate on cystoprostatectomy specimen in patients treated with radiotherapy for prostate cancer, International Urology and Nephrology, 52, 2, 2020. Crossref

  2. Seifert Michael, Peitzsch Claudia, Gorodetska Ielizaveta, Börner Caroline, Klink Barbara, Dubrovska Anna, Lazzara Matthew J., Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse, PLOS Computational Biology, 15, 11, 2019. Crossref

  3. Lindell Jonsson Eva, Erngren Ida, Engskog Mikael, Haglöf Jakob, Arvidsson Torbjörn, Hedeland Mikael, Petterson Curt, Laurell Göran, Nestor Marika, Exploring Radiation Response in Two Head and Neck Squamous Carcinoma Cell Lines Through Metabolic Profiling, Frontiers in Oncology, 9, 2019. Crossref

  4. Labbé Maureen, Hoey Christianne, Ray Jessica, Potiron Vincent, Supiot Stéphane, Liu Stanley K., Fradin Delphine, microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation, Molecular Cancer, 19, 1, 2020. Crossref

  5. Zhang Jiani, Ding Lixin, Sun Gaofeng, Ning Huacheng, Huang Ruixue, Suppression of LINC00460 mediated the sensitization of HCT116 cells to ionizing radiation by inhibiting epithelial–mesenchymal transition, Toxicology Research, 9, 2, 2020. Crossref

  6. Li Yan, Cho Mi Hyeon, Lee Seon Sook, Lee Dong-Eun, Cheong Heesun, Choi Yongdoo, Hydroxychloroquine-loaded hollow mesoporous silica nanoparticles for enhanced autophagy inhibition and radiation therapy, Journal of Controlled Release, 325, 2020. Crossref

  7. Zubor Pavol, Wang Yun, Liskova Alena, Samec Marek, Koklesova Lenka, Dankova Zuzana, Dørum Anne, Kajo Karol, Dvorska Dana, Lucansky Vincent, Malicherova Bibiana, Kasubova Ivana, Bujnak Jan, Mlyncek Milos, Dussan Carlos Alberto, Kubatka Peter, Büsselberg Dietrich, Golubnitschaja Olga, Cold Atmospheric Pressure Plasma (CAP) as a New Tool for the Management of Vulva Cancer and Vulvar Premalignant Lesions in Gynaecological Oncology, International Journal of Molecular Sciences, 21, 21, 2020. Crossref

  8. Omelchuk E. P., Kutilin D. S., Dimitriadi S. N., Gusarev M. A., Timoshkina N. N., Molecular genetic aspects of prostate cancer radioresistance, Bulletin of Siberian Medicine, 20, 3, 2021. Crossref

  9. Lou Dandan, Zhu Daoqi, Wang Zetai, Zhang Ruhua, Yu Zhijian, Gong Fengying, Peng Yan, Zeng Siying, Liu Ying, Li Aiwu, Fan Qin, Effect of GADD45G on the radioresistance of nasopharyngeal carcinoma cells, Anti-Cancer Drugs, 33, 1, 2022. Crossref

  10. Doldi Valentina, El Bezawy Rihan, Zaffaroni Nadia, MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer, Cancers, 13, 10, 2021. Crossref

  11. Fasolino Ines, Soriente Alessandra, Caporali Maria, Serrano-Ruiz Manuel, Peruzzini Maurizio, Ambrosio Luigi, Raucci Maria Grazia, 2D exfoliated black phosphorus influences healthy and cancer prostate cell behaviors, Scientific Reports, 11, 1, 2021. Crossref

  12. Ba Shuang, Yu Ming, Ultrasound-stimulated microbubbles enhances radiosensitivity of ovarian cancer, Acta Radiologica, 2021. Crossref

  13. Balázs Katalin, Antal Lilla, Sáfrány Géza, Lumniczky Katalin, Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients, Journal of Personalized Medicine, 11, 4, 2021. Crossref

  14. Verma Elika, Kumar Aviral, Devi Daimary Uzini, Parama Dey, Girisa Sosmitha, Sethi Gautam, Kunnumakkara Ajaikumar B., Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review, Journal of Functional Foods, 86, 2021. Crossref

  15. Fan Yao, Fan Hui, Quan Zhen, Wu XiaoHou, Ionizing Radiation Combined with PARP1 Inhibitor Reduces Radioresistance in Prostate Cancer with RB1/TP53 Loss, Cancer Investigation, 39, 5, 2021. Crossref

  16. Rajput Mohit, Singh Ragini, Singh Navneendra, Singh Rana P., EGFR-mediated Rad51 expression potentiates intrinsic resistance in prostate cancer via EMT and DNA repair pathways, Life Sciences, 286, 2021. Crossref

  17. Chen Yu-An, Lai Yi-Ru, Wu Hui-Yu, Lo Yen-Ju, Chang Yu-Fang, Hung Chiu-Lien, Lin Chun-Jung, Lo U-Ging, Lin Ho, Hsieh Jer-Tsong, Chiu Cheng-Hsun, Lin Yu-Hsin, Lai Chih-Ho, Bacterial Genotoxin-Coated Nanoparticles for Radiotherapy Sensitization in Prostate Cancer, Biomedicines, 9, 2, 2021. Crossref

  18. Tsakanova Gohar, Stepanyan Ani, Arakelova Elina, Ayvazyan Violetta, Tonoyan Vahan, Arakelyan Arsen, Hildebrandt Guido, Schültke Elisabeth, Tilaoui Mounir, The radioenhancement potential of Schiff base derived copper (II) compounds against lung carcinoma in vitro, PLOS ONE, 16, 6, 2021. Crossref

  19. Carlos-Reyes Angeles, Muñiz-Lino Marcos A., Romero-Garcia Susana, López-Camarillo César, Hernández-de la Cruz Olga N., Biological Adaptations of Tumor Cells to Radiation Therapy, Frontiers in Oncology, 11, 2021. Crossref

  20. Papanikolaou Sofia, Vourda Aikaterini, Syggelos Spyros, Gyftopoulos Kostis, Cell Plasticity and Prostate Cancer: The Role of Epithelial–Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance, Cancers, 13, 11, 2021. Crossref

  21. Adamaki Maria, Zoumpourlis Vassilios, Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics, Pharmacology & Therapeutics, 228, 2021. Crossref

  22. Zhou Keqin, Wei Yongbao, Li Xurui, Yang Xin, MiR-223-3p targets FOXO3a to inhibit radiosensitivity in prostate cancer by activating glycolysis, Life Sciences, 282, 2021. Crossref

  23. Saxby Helen, Boussios Stergios, Mikropoulos Christos, Androgen Receptor Gene Pathway Upregulation and Radiation Resistance in Oligometastatic Prostate Cancer, International Journal of Molecular Sciences, 23, 9, 2022. Crossref

  24. Jasinski Milosz, Olszewska-Slonina Dorota, Serum Paraoxonase-1 Activity and the Risk of Prostate Cancer Recurrence in Patients Treated with Radiotherapy, Antioxidants, 11, 2, 2022. Crossref

  25. Marques Ana, Belchior Ana, Silva Francisco, Marques Fernanda, Campello Maria Paula Cabral, Pinheiro Teresa, Santos Pedro, Santos Luis, Matos António P. A., Paulo António, Dose Rate Effects on the Selective Radiosensitization of Prostate Cells by GRPR-Targeted Gold Nanoparticles, International Journal of Molecular Sciences, 23, 9, 2022. Crossref

  26. Naushad Shaik Mohammad, Kutala Vijay Kumar, Systems Biology and Bioinformatics Approaches Unraveling the Therapeutic Potential of Novel Drugs in Counteracting the Oxidative Stress Adaptation in Prostate Cancer, in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects, 2022. Crossref

  27. Makhotkin M. A., Chebotarev D. A., Tyutyakina M. G., Mashkarina A. N., Tarasov V. A., Kogan M. I., Chernogubova E. A., The role of microRNAs in the development of radioresistance of prostate cancer cells (experimental study), Cancer Urology, 17, 4, 2022. Crossref

  28. Ke Zhi-Bin, You Qi, Chen Jia-Yin, Sun Jiang-Bo, Xue Yu-Ting, Zhuang Rui-Bin, Zheng Qing-Shui, Chen Ye-Hui, Wei Yong, Sun Xiong-Lin, Xue Xue-Yi, Xu Ning, A radiation resistance related index for biochemical recurrence and tumor immune environment in prostate cancer patients, Computers in Biology and Medicine, 146, 2022. Crossref

  29. Qian Duocheng, Li Quan, Zhu Yansong, Li Dujian, Comprehensive Analysis of Key Proteins Involved in Radioresistance of Prostate Cancer by Integrating Protein-protein Interaction Networks, Current Bioinformatics, 16, 1, 2021. Crossref

  30. Zhang Yida, He Lile, Sadagopan Ananthan, Ma Tao, Dotti Gianpietro, Wang Yufeng, Zheng Hui, Gao Xin, Wang Dian, DeLeo Albert B., Fan Song, Sun Ruochuan, Yu Ling, Zhang Liyuan, Wang Gongxian, Ferrone Soldano, Wang Xinhui, Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells, Molecular Cancer Therapeutics, 20, 3, 2021. Crossref

  31. Mirzaei Sepideh, Paskeh Mahshid Deldar Abad, Okina Elena, Gholami Mohammad Hossein, Hushmandi Kiavash, Hashemi Mehrdad, Kalu Azuma, Zarrabi Ali, Nabavi Noushin, Rabiee Navid, Sharifi Esmaeel, Karimi-Maleh Hassan, Ashrafizadeh Milad, Kumar Alan Prem, Wang Yuzhuo, Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention, Journal of Experimental & Clinical Cancer Research, 41, 1, 2022. Crossref

  32. Owari Takuya, Tanaka Nobumichi, Nakai Yasushi, Miyake Makito, Anai Satoshi, Kishi Shingo, Mori Shiori, Fujiwara-Tani Rina, Hojo Yudai, Mori Takuya, Kuwada Masaomi, Fujii Tomomi, Hasegawa Masatoshi, Fujimoto Kiyohide, Kuniyasu Hiroki, 5-Aminolevulinic acid overcomes hypoxia-induced radiation resistance by enhancing mitochondrial reactive oxygen species production in prostate cancer cells, British Journal of Cancer, 127, 2, 2022. Crossref

  33. Zhu Xueru, Wang Yiting, Jiang Chang, Li Xiaoyang, Sun Linying, Wang Guangzhong, Fu Xiaolong, Radiosensitivity-Specific Proteomic and Signaling Pathway Network of Non-Small Cell Lung Cancer (NSCLC), International Journal of Radiation Oncology*Biology*Physics, 112, 2, 2022. Crossref

  34. Sutera Philip, Deek Matthew P., Van der Eecken Kim, Wyatt Alexander W., Kishan Amar U., Molitoris Jason K., Ferris Matthew J., Siddiqui M. Minhaj, Rana Zaker, Mishra Mark V., Kwok Young, Davicioni Elai, Spratt Daniel E., Ost Piet, Feng Felix Y., Tran Phuoc T., Genomic biomarkers to guide precision radiotherapy in prostate cancer, The Prostate, 82, S1, 2022. Crossref

  35. Naushad Shaik Mohammad, Kutala Vijay Kumar, Systems Biology and Bioinformatics Approaches Unraveling the Therapeutic Potential of Novel Drugs in Counteracting the Oxidative Stress Adaptation in Prostate Cancer, in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects, 2022. Crossref

  36. Miller Caitlin E., Xu Fangfang, Zhao Yanming, Luo Wei, Zhong Weixiong, Meyer Kristy, Jayswal Rani, Weiss Heidi L., St. Clair William H., St. Clair Daret K., Chaiswing Luksana, Hydrogen Peroxide Promotes the Production of Radiation-Derived EVs Containing Mitochondrial Proteins, Antioxidants, 11, 11, 2022. Crossref

  37. Sathekge Mike, Bruchertseifer Frank, Vorster Mariza, Lawal Ismaheel O., Knoesen Otto, Mahapane Johncy, Davis Cindy, Mdlophane Amanda, Maes Alex, Mokoala Kgomotso, Mathabe Kgomotso, Van Christophe, Wiele de, Morgenstern Alfred, mCRPC Patients Receiving 225Ac-PSMA-617 Therapy in the Post–Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis, Journal of Nuclear Medicine, 63, 10, 2022. Crossref

  38. Marinescu Ioana M., Rogg Manuel, Spohn Simon, von Büren Moritz, Kamps Marius, Jilg Cordula A., Fountzila Elena, Papadopoulou Kyriaki, Ceci Lara, Bettermann Alisa, Ruf Juri, Benndorf Matthias, Adebahr Sonja, Zips Daniel, Grosu Anca L., Schell Christoph, Zamboglou Constantinos, Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters, Radiation Oncology, 17, 1, 2022. Crossref

  39. Sideri Silvia, Petragnano Francesco, Maggio Roberto, Petrungaro Simonetta, Catizone Angela, Gesualdi Luisa, De Martino Viviana, Battafarano Giulia, Del Fattore Andrea, Liguoro Domenico, De Cesaris Paola, Filippini Antonio, Marampon Francesco, Riccioli Anna, Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications, Cancers, 14, 22, 2022. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain